These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 32016786

  • 1. Retransplantation after post transplant lymphoproliferative disorder: overcoming the obstacles!
    Prasad P, Khullar D, Gupta N, Grover R, Chhabra G, Gandhi KR, Gupta S, Bagai S.
    CEN Case Rep; 2020 Aug; 9(3):200-203. PubMed ID: 32016786
    [Abstract] [Full Text] [Related]

  • 2. Remission of Epstein-Barr virus-positive post-transplant lymphoproliferative disorder by conversion to everolimus in a kidney transplant recipient.
    Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T.
    Transpl Infect Dis; 2019 Aug; 21(4):e13116. PubMed ID: 31102475
    [Abstract] [Full Text] [Related]

  • 3. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
    Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B, French PTLD Registry.
    Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1663-1670. PubMed ID: 28818847
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients.
    Ishihara M, Tanaka E, Sato T, Chikamoto H, Hisano M, Akioka Y, Dohno S, Maeda A, Hattori M, Wakiguchi H, Fujieda M.
    Clin Nephrol; 2011 Jul 06; 76(1):40-8. PubMed ID: 21722604
    [Abstract] [Full Text] [Related]

  • 5. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 06; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan 06; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 7. Biomarkers for PTLD diagnosis and therapies.
    Martinez OM.
    Pediatr Nephrol; 2020 Jul 06; 35(7):1173-1181. PubMed ID: 31240394
    [Abstract] [Full Text] [Related]

  • 8. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 06; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 9. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Jan 06; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 10. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 06; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 11. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec 06; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 12. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
    Ferguson NN, Thomas CP, Hohl RJ, Syrbu SI, Stone MS, Wanat KA.
    Am J Dermatopathol; 2015 Oct 06; 37(10):790-4. PubMed ID: 25747810
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
    Kalra A, Roessner C, Jupp J, Williamson T, Tellier R, Chaudhry A, Khan F, Taparia M, Jimenez-Zepeda VH, Stewart DA, Daly A, Storek J.
    Clin Transplant; 2018 Jan 06; 32(1):. PubMed ID: 29114932
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice.
    Clin Transplant; 2019 Sep 06; 33(9):e13652. PubMed ID: 31230381
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Sep 06; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW, Lee V, To KF, Chan KC, Shing MK, Li CK.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1329-31. PubMed ID: 19591223
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
    Birkeland SA, Hamilton-Dutoit S, Bendtzen K.
    Transplantation; 2003 Jul 15; 76(1):153-8. PubMed ID: 12865802
    [Abstract] [Full Text] [Related]

  • 18. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA, Meier JD, Stallworth CR, White DR.
    Ann Otol Rhinol Laryngol; 2012 May 15; 121(5):291-5. PubMed ID: 22724273
    [Abstract] [Full Text] [Related]

  • 19. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov 15; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 20. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug 15; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.